Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track AWHL with free AI briefings, catalyst countdowns, and dilution alerts.

AWHL · Aspira Women's Health Inc.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$477,000 Cash on Hand
1.2mo Cash Runway
Follow AWHL by email Get an email when AWHL reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about AWHL, unsubscribe in one click. Privacy

📄 Latest SEC Filings in Plain English

Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.

🧪 Trial & FDA Catalysts

💰 Cash Runway & Dilution Risk

AWHL holds $477,000 in cash and short-term investments (as of Jun 30, 2026) and burns about $1.2M/quarter from operations, an estimated runway of 1.2 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 80 · High

Recent financing filings on SEC EDGAR:

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when AWHL files for a raise →

👥 Who Owns AWHL

Insiders 12.6% Institutions (3 holders) 0.8% Public and other holders 86.6%
HolderTypeShares% of sharesAs of
Jack W Schuler
10% owner · +2.98M options
Insider 4,052,587 8.69% 2026-06-05
John D Fraser
Director · +1.30M options
Insider 854,162 1.83% 2025-09-17
Jeffrey k cohen
Director · +705,503 options
Insider 457,028 0.98% 2025-09-19
John Phillip Ragard
Director
Insider 134,734 0.29% 2025-06-04
Jannie Prestridge Herchuk
Director
Insider 82,502 0.18% 2025-06-04
Stefanie L. Cavanaugh
Director
Insider 78,726 0.17% 2025-06-04
Ellen O'Connor Vos
Director
Insider 73,989 0.16% 2025-06-04
Winfred Parnell
Director · +185,178 options
Insider 71,209 0.15% 2025-06-04
Celeste Rachelle Fralick
Director · +5,000 options
Insider 55,665 0.12% 2025-03-31
Ellen Beausang
Director · +198,097 options
Insider 6,458 0.01% 2025-06-04

Share count 46,633,744 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest. Sources have different dates, so the split is approximate. Source: SEC EDGAR.

Get the full AWHL picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for AWHL and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.